Back Holst, JJ (2024) The Story of GLP-1: A historical journey in the treatment of diabetes and obesity
I don't know what else I can do." That's when he suggested Zepbound, a GLP-1 drug for obesity
Experts say taste and smell dysfunction doesnt appear to be a common side effect of GLP-1s, which are widely prescribed for weight loss
Workshop: Popular GLP-1 RA Weight Loss and Diabetes Drugs Are you taking or thinking about taking the new GLP-1 RA weight loss medications (Semaglutide, Ozempic, Wegovy, Tirzepatide, Mounjaro, Zepbound)
Crucially, glucagon receptor activation stimulates energy expenditure through GcgR-mediated thermogenesis and lipolysis an effect counterbalanced by concurrent GLP-1R activity that prevents net hyperglycaemia
sites, tirzepatide was directly compared to semaglutide 2.4 mg in 751 adults with obesity or overweight without type 2 diabetes